Crilomus 0.5 mg
Crilomus 0.5 mg is a medicine authorised by Swissmedic under authorisation number 59322. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 September 2009 and the authorisation is valid without a time limit. ATC code L04AD02 places the medicine in the group Immunosuppressants.
| Authorisation number | 59322 |
|---|---|
| Name | Crilomus 0.5 mg |
| Full name | Crilomus 0.5 mg, Kapseln |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AD02 |
| First authorisation | 03 September 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Crilomus 0.5 mg, Kapseln | A | 03 September 2009 |
| 2 | Crilomus 1 mg, Kapseln | A | 03 September 2009 |
| 3 | Crilomus 5 mg, Kapseln | A | 03 September 2009 |
| 4 | Crilomus 0.75 mg, Kapseln | A | 24 July 2014 |
| 5 | Crilomus 2 mg, Kapseln | A | 24 July 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 50 | Kapsel(n) | L04AD02 | 07.15.0. | A |
| 7 | 50 | Kapsel(n) | L04AD02 | 07.15.0. | A |
| 8 | 50 | Kapsel(n) | L04AD02 | 07.15.0. | A |
| 11 | 50 | Kapsel(n) | L04AD02 | 07.15.0. | A |
| 12 | 50 | Kapsel(n) | L04AD02 | 07.15.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Crilomus 0.5 mg authorised in Switzerland?
Yes. Crilomus 0.5 mg is authorised by Swissmedic under authorisation number 59322, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Crilomus 0.5 mg have?
Crilomus 0.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Crilomus 0.5 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.